NOVAVAX Announces Release Date of 2009 Year-End Financial Results and Investor Conference Call

Friday, March 5, 2010 General News J E 4

ROCKVILLE, Md., March 4 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will report its 2009 year-end financial results in a press release to be issued after 8:00 a.m. local time on Friday, March 12, 2010. The Company will hold an investor conference call to discuss its financial results at 10:00 a.m. local time on Friday, March 12, 2010. The call will be hosted by Novavax President and Chief Executive Officer Dr. Rahul Singhvi and other members of senior management. A question and answer session will follow the overview of the financial results. The dial-in number for the conference call is 1 (866) 804 3550 (U.S. or Canada) or 1 (703) 639-1330 (International).  

A live audio webcast of the conference call will be available at under Investors/Events. Please connect to this website at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be needed to hear the webcast. A replay of the conference call will be available on Novavax's website approximately one hour after the event for 90 days and a replay of the conference call will also be available by telephone beginning March 12, 2010 at 1:00 pm through March 14, 2010 at 11:59 pm. To access the replay, dial 1 (888) 266 2081 and enter pass code 1412843.

About Novavax, Inc.

Novavax, Inc. is a clinical-stage biotechnology company creating novel vaccines to address a broad range of infectious diseases worldwide, including H1N1, using advanced proprietary virus-like-particle (VLP) technology.  The company produces potent VLP-based recombinant vaccines utilizing new and efficient manufacturing approaches.  Novavax is committed to using its VLP technology to create country-specific vaccine solutions.  The company has formed a joint venture with Cadila Pharmaceuticals, named CPL Biologicals, to develop and manufacture vaccines, biological therapeutics and diagnostics in India. Additional information about Novavax is available on the company's website:

SOURCE Novavax, Inc.



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Urgent Update - The Noon Media Call Is Cancelled. ...
'What Moves You?' Video Contest and Statewide Even...